{"id":6994,"date":"2025-05-28T11:05:17","date_gmt":"2025-05-28T09:05:17","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/us\/?post_type=pipelines&#038;p=6994"},"modified":"2025-07-10T11:04:14","modified_gmt":"2025-07-10T09:04:14","slug":"zanubrutinib-btk-inhibitor","status":"publish","type":"pipelines","link":"https:\/\/beonemedaffairs.com\/us\/pipelines\/6994\/zanubrutinib-btk-inhibitor\/","title":{"rendered":"Zanubrutinib (BTK inhibitor)"},"content":{"rendered":"","protected":false},"template":"","meta":{"_acf_changed":false,"editor_notices":[]},"class_list":["post-6994","pipelines","type-pipelines","status-publish","hentry","molecule-zanubrutinib","compound_type-small-molecule"],"acf":{"indications_repeater":[{"indication":"Primary membranous nephropathy","disease_state":null,"phase":3,"countries":[],"status":"ongoing"},{"indication":"Lupus nephritis","disease_state":null,"phase":2,"countries":[],"status":"ongoing"}],"cancer_type":["190"],"compound_type":422,"custom_link":{"title":"Mode of Action video","url":"https:\/\/beonemedaffairs.com\/us\/6353\/zanubrutinib-moa-video\/","target":""}},"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/pipelines\/6994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/pipelines"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/types\/pipelines"}],"acf:term":[{"embeddable":true,"taxonomy":"compound_type","href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/compound_type\/422"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/media?parent=6994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}